In this week's OWOH #podcast, @AislinnCook of @CNPI_AMR & @HERC_Oxford tells us some concrete achievable goals she & co-authors of @TheLancet series on #AMR found that the world can work toward to control the spread of drug-resistant germs. Listen here: https://t.co/eH7OqtZtm9
“The problem of [antimicrobial resistance (AMR)] has been seen as either not urgent or too difficult to solve. Neither is true.”
🆕 A Lancet Series spotlights this global issue & how existing infection prevention methods could save 750,000 lives a year: https://t.co/Z7oWFNTJMS
Calling all #NICUs 🏥👶 Join the next online training on how to use the NeoIPC toolkit for #surveillance of hospital-acquired infections (#HAI) in neonatology! Free to attend & no prerequisites.
📅 15th April
⏰ 13:30-16:15 CEST
🔍 Info & registration: https://t.co/Xgw08gEP9R
Aiming to increase #AWaReNess and reducing #AMR and inappropriate prescribing, #ADILA (AMR/AMU data to inform local action) is a @Wellcome-trust funded project that seeks to inform local guidance to improve empirical antibiotic prescribing considering local AMR-patterns...cont'd
We are seeking an enthusiastic and organised #data manager to work on the NeoDeco study, a hybrid implementation-effectiveness cluster randomised #trial of optimised #kangaroocare as an #IPC intervention in high-technology #neonatal care.
#JobAlert
https://t.co/fMbvfCHBFq
Are you attending #INAC2023 in Dublin 🇮🇪 this weekend?
Make sure you don't miss the presentation "#NeoIPC project: Reducing #Sepsis in the NICU" by Jennifer Martin (@AMR_CNPI)!
ℹ️ Join Concurrent Session 9: Quality improvement initiatives in #NICU
🗓️ Sat, 9 Sept, 3:15pm BST
Great to see our GARDP-sponsored study on #neonatalsepsis published in a Special Issue on #AMR in @PLOSMedicine
Well done to our partners and study sites across 19 hospitals in 11 countries 👏
👉https://t.co/cSUglEdY6p
A global study co-led by researchers at St George’s highlights newborn deaths from sepsis and burden of antibiotic resistance.
The results provide a wealth of high-quality data which researchers hope will improve sepsis treatment for newborns.
Read more: https://t.co/zZBQTbmcyp
Very excited to announce that the findings of GARDP’s #neonatalsepsis study are now available in @PLOSMedicine!
This observational study is aimed at improving the treatment of newborn babies with #sepsis
Read now 👇
https://t.co/jV7hVyI8sc
#AntibioticResistance#AMR
NEW PUBLICATION 📚
Findings from the #NeoObs study on #NeonatalSepsis are now available on @PLOSMedicine!
This observational study, led by @gardp_amr, shed light on how #AMR impacts mortality rates of newborns with #sepsis.
More on the study results 👉
https://t.co/98fVhIkuxv
Our #AMR team are looking forward to presenting at this event with @UKAMREnvoy, including our Chief Investigator Prof. Mike Sharland👏
Get your free ticket to the online webinar using the QR code/link seen below, and please share this tweet!❤️
#antibiotics#AWaRe#globalpolicy
Happy International Clinical Trials Day!🌎
Such an important day to celebrate all of the global trials being conducted at St George's - thank you to all of our participants worldwide for contributing to healthcare research!👏
#ClinicalTrialsDay#BePartOfResearch#VaccinesWork
At #ECCMID23, @AislinnCook presented results from 4 cross-sectional surveys looking at #antibiotic use in neonatal care 👶, conducted in 18 European #NICUs participating in the #NeoIPC colonisation feasibility assessment. Here's what was found👇
Poster ➡️ https://t.co/eZlbiDzWXv
This morning's #ECCMID2023 talks include results from the NeoOBS trial, showing that higher dosing of colistin may reduce mortality in newborns with carbapenem-resistant infections #AMR.
@StGeorgesUni@gardp_amr@AMR_CNPI
#ECCMID2023: Michelle Clements (UK): Higher colistin dosing associated with a lower mortality in neonates with CR infections; from NeoOBS study, using NeoSEP severity scores https://t.co/YnvnSjRx8I